Rhapsido (remibrutinib) - Novartis
Remibrutinib as a Therapeutic Option for Solar Urticaria. (PubMed, Photodermatol Photoimmunol Photomed) - Oct 7, 2026 - No abstract available 
Journal • Dermatology • Immunology • Urticaria
http://www.ncbi.nlm.nih.gov/pubmed/42836496
 
Johanna Gonzalez; Joshua Mijares; Manoj Bhagwat; Vignesh Ramachandran
 
Oct 7, 2026
 
Prev Next